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COPPER EXCHANGE STUDIES BETWEEN THE FIRST AND FOURTH N
TERMINAL METAL-BINDING DOMAINS OF
WILSON DISEASE ATPASE
Jennifer Bunce, M.S.
Western Michigan University, 2005
The human copper-transporting ATPase Wilson's disease protein was one of
the first proteins shown to be actively involved in cellular copper homeostasis. The
protein includes six N-terminal metal binding domains. The individual capabilities of
the domains to bind and transfer copper are not yet fully understood. Each metal
binding domain is about 72 amino acid residues long and contains the conserved
binding motif GMTCXXC, of which the cysteines are involved in the copper
coordination. Studies have shown that the protein binds six copper atoms suggesting
the potential involvement of each metal-binding domain. Separate functional roles
for the latter domains have been proposed implicating a possible interaction between
the domains.
Here the first and fourth domains have been isolated and characterized by
several chemical means including high resolution gel filtration, MALDI mass
spectroscopy, and isoelectric focusing. Each domain demonstrated copper binding
capabilities. Copper exchange activity has demonstrated between the two individual
metal-binding domains in vitro using varying molar ratios between donor and
acceptor. The exchange event was determined to be reversible and equilibrium was
quickly achieved in less than 5 minutes. The
for the reaction.

Kexchange

constant is estimated at 0.69
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CHAPTER I
INTRODUCTION
Copper Homeostasis ·
Copper is an essential trace metal required by both prokaryotes and
eukaryotes (Linder, 1991). Many metalloenzymes require copper as a catalytic
cofactor in various redox reactions. Some of these enzymes and their associated
biological functions include cytochrome c oxidase for oxidative metabolism,
dopamine monooxygenase for neurotransmitter synthesis, superoxide dismutase for
free radical detoxification, ceruloplasmin for iron uptake, and lysl oxidase for
maturation of connective tissue (Danks, 1995). While the nutrient requirement of
copper is essential, excess copper is toxic (Vulpe, 1995). As a transition metal,
copper is able to participate in reactions which generate reactive oxidative species
(ROS). ROS cause oxidative damage to biological molecules such as proteins, lipids,
and nucleic acids. Consequently, intracellular copper concentrations must be
stringently regulated to ensure bioavailability to essential enzymes while preventing
accumulation to toxic levels.
Recent studies, employing yeast as a eukaryotic model system, suggested the
intracellular free copper concentration to be less than one atom per cell necessitating
a copper carrier for transport to target proteins (Rae, 1999). The lack of "free"
copper ion quantities is due to an overcapacity to chelate copper within the cell. For
this reason, there are several copper receptors which function to facilitate the
transport of copper to selective proteins. These copper receptors are part of a class of
proteins called metallochaperones (Pufahl, 1997). Several metallochaperones have
1
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evolved to form specific pathways for the proper trafficking of copper within cells
(O'Halloran, 2000). Metallochaperones function to bind and protect metals from
intracellular chelation and non-specific binding during their conveyance and ensuing
transfer to specific partner proteins. In addition to copper chaperones, copper
transporting P-type ATPases play an important role in copper trafficking. P-Type
ATPases are membrane-bound heavy metal transporters responsible for the active
transport of cations across cell membranes. ATPases hydrolyze ATP to drive the
metal transport process resulting in either metal uptake or efflux. Studies have shown
that these copper trafficking proteins, both metallochaperones and P-type ATPases,
are highly conserved across species and homologs have been identified in bacteria,
yeast, plants, and mammals (Arnesano, 2001b; Rosenzweig, 2001; Solioz, 1994).
Overview of Copper Metabolism
Presented is an outline of a proposed model for copper metabolism at the
cellular level as illustrated in Figure 1 (review Pefia, 1999; review Camakaris, 1999).
Estimates of human daily dietary intake of copper range from 0.6 to 1.6 mg per day
(Linder, 1996). Predominantly this copper is absorbed from the cells lining the
stomach and the small intestine. Copper must first be reduced from the assumed
Cu(II) oxidation state to Cu (I) before entering the cell and this event is thought to
take place either prior to or during uptake by a hypothetical reductase. Uptake of
copper into cells occurs via a high affinity permease, hCtrl (Puig, 2002; Lee, 2002).
In the cytoplasm, copper is bound by copper chaperones which shuttle the metal to
specific target proteins. Important cuproproteins are located within multiple
endoplasmic reticulum, and secretory vesicles. Several distinct pathways of copper
trafficking have been established (review O'Halloran, 2000). Examples of this
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Figure 1. Model of Cellular Copper Metabolism
specific copper distribution by metallochaperones include (a) hCOXl 7 shuttling of
copper to the mitochondria (Amaravadi, 1997), essential for incorporation of copper
into the enzyme cytochrome c oxidase, (b) Ccsl copper delivery to S0D1 (Culotta,
1997), a Cu/Zn superoxide dismutase, and (c) Atoxl transporting copper to the
secretory pathway (Klomp, 1997) via interaction with the copper-transporting
ATPases Wilson disease protein (WOP) or Menkes disease protein (MNK).

Human Genetic Defects in Copper Transport
The discovery of the genes responsible for the two genetic disorders
associated with defects in copper metabolism, Menkes (Vulpe, 1993) and Wilson's
(Bull, 1993) diseases has generated renewed interest in the molecular mechanisms of
copper transport.
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Menkes Disease
Menkes disease is an X-linked recessive disorder characterized by severe
copper deficiency due to reduction of dietary copper absorption (Menkes, 1962).
Patients with Menkes disease exhibit neurodegeneration, developmental
complications, connective tissue abnormalities, and usually do not survive past early
childhood (Menkes, 1962). These symptoms are a result of the lack of copper
incorporation into several developmentally important cuproproteins (Danks, 1972).
The disease arises from mutations in the gene encoding for the P-type
ATPase, named ATP7A. ATP7A has been genetically mapped to the q13 region of
the X-chromosome and encodes a protein consisting of 1500 amino acid residues
(Vulpe, 1993). Menkes disease protein (MNK) transports copper into the secretory
pathway of the gastrointestinal tract, placenta, and blood-brain barrier (review Danks,
1995). MNK is also responsible for exporting copper from other tissues notably, the
intestinal mucosa (review Danks, 1995). MNK is highly expressed in most tissues
with the exception of the liver (Vulpe, 1993; Paynter, 1994). Accordingly, mutations
of the MNK gene result in copper accumulation in those tissues where ATP7A is
highly expressed specifically the kidney, duodenum, and placenta, while a severe
copper deficiency develops in most other tissues.
Wilson's Disease
Wilson's disease is an autosomal recessive disorder of copper homeostasis
distinguished by increased copper accumulation in the liver, kidneys, and brain
(Wilson, 1912). Patients exhibit symptoms of liver cirrhosis, renal dysfunction, and
neuronal degeneration (Brewer, 1992). Many patients are diagnosed by the
characteristic Kayser-Fleischer rings visible on the cornea (Kayser, 1902; Fleischer,

5
1903). At the cellular level the disease is characterized by a failure ofhepatocytes to
incorporate copper into the ceruloplasmin (Scheinberg, 1952) and a marked decrease
ofcopper excretion in the bile (Suzuki, 1994; Terada, 1999).
Wilson's disease is caused by mutations in the gene encoding for the P-type
ATPase ATP7B, a gene highly homologous to ATP7A in structure and function
(Bull, 1993). ATP7B is located on chromosome 13 at q14.3 and comprises 80 kb of
genomic DNA and 21 exons. The P-type ATPase protein produced is 1411 amino
acid residues long (Yamaguchi, 1993).
Wilson disease protein (WDP) is expressed primarily in the liver, secondarily
in the kidneys, and to a lesser degree in the brain, heart, and lungs (Bull, 1993). Most
dietary copper is deposited in the liver where the production ofbile occurs; bile is a
primary excretion pathway for copper (Linder, 1991). WDP is located within the
trans-Golgi network and is essential for incorporating copper into ceruloplasmin
(Terada, 1998), a multicopper oxidase with ferroxidase activity that is the most
abundant copper-binding protein in the blood plasma.
MNK and WDP Roles in Copper Transport
Although MNK shares a high homology level to WDP both in manners of
structure and function, the two proteins are expressed in different tissues and thus
serve different physiological roles. The means by which these two P-type ATPases
contribute to copper homeostasis are not yet fully understood. Many recent studies
have been published in an effort to elucidate the molecular mechanism for each
protein. Several areas ofinterest exist concerning MNK and WDP. Among the most
extensively examined topics are the protein structure, metal specificity, cellular
localization, interaction with metallochaperone Atoxl , distinguishing the roles of
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different domains within the proteins, and regulation of protein catalytic activity by
copper, external factors or self-regulation.
Conserved Domains in Copper-Transporting ATPases
The mechanisms of copper-transport for P-type ATPases are thought to be
evolutionarily retained. An example of this mechanistic preservation is illustrated by
complementation studies of MNK and WOP and their yeast homologue, Ccc2. Ccc2
provides copper to the Fet3p multicopper oxidase, a homologue of human
ceruloplasmin (Yuan, 1995). MNK and WOP were each able to restore copper
incorporation into Fet3p when expressed in a Ccc2 deficient yeast strain (Payne,
1998; Iida, 1998).
Significant structural motifs are conserved in all heavy-metal-transporting P
type ATPases with additional discerning traits for those ATPases specific for copper
transport (Bull, 1994; Lutsenko, 1995; Lieberman, 2004) an illustration of these
conserved motifs is provided in Figure 2. Among these common features are the
eight transmembrane domains, of which the sixth segment contains the highly
conserved intramembrane sequence CPC. The conserved cysteines of the CPC motif
are thought to serve as the metal-binding site during copper transport across the
membrane. Specific to the copper-transporting ATPases but not all heavy-metal
transporting ATPases is the conserved sequence of YN located in the seventh
transmembrane domain. P-type ATPases transporting other heavy metals such as
zinc and cadmium lack this YN motif (Lutsenko, 2002). Recently this motif was
determined to effect the copper coordination of the Cu-transporting P-type ATPase
CopA using mutational analysis (Mandal, 2004).
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Figure 2. Generalized Structure of a Copper-transporting P-type ATPase
Copper-transporting ATPases are comprised of four major conserved domains: eight
transmembrane segments (TM), an ATP-binding domain (ATP-BD), an actuator
domain (A), and the one-six metal-binding N-terminus domains (M).
The remaining conserved domains of copper-transporting ATPases are found
within the cytosolic loops of the membrane-bound protein. An ATP-binding site is
situated in the loop between the sixth and seventh transmembrane domains
Tsivkovskii, 2001). The ATP-binding site can be divided into two parts, a
phosphorylation site, and a nucleotide binding site. The phosphorylation site is
comprised of the invariant sequence DKTG, where the aspartic acid is
phosphorylated during ATP hydrolysis. The nucleotide-binding site, containing
conserved sequence SEHPL, is believed to bind adenine from ATP. Situated in the
cytosolic loop between the fourth and fifth transmembrane domains lies the actuator
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domain, sequence motif TGE. The actuator domain name alludes to its role of
interacting with the ATP-binding site, a requisite for conformational changes to occur
which are necessary for catalytic transport activity of the protein (Toyoshima, 2000).
Intriguingly the most variability within the conserved domains of the copper
transporting ATPases is found in the N-terminal metal binding domains (MBOs).
Although all copper-transporting ATPases have at least one metal-binding domain,
they may contain as many as six MBOs. These MBOs each are approximately 70
amino acid residues in length, and possess the highly conserved metal-binding
sequence GMTCXXC. A sequence alignment of the six MBOs of WOP is shown in
Figure 3 with the conserved metal-binding region boxed. The conserved cysteines
each contribute a metal binding ligand to complex copper. While the structures for
most copper-transporting ATPases are as yet undetermined, recent NMR solution
structures for select individual MBOs are available. Structures recently solved
include those for MNK MBO2, apo and Cu (!)-bound forms (Banci, 2004), MNK
MBO4, apo and Ag (!)-bound forms (Gitschier, 1998), and the first MBO of the yeast
homolog Ccc2, apo and Cu (!)-bound forms (Banci, 2001). Homology models
predict that N-MBOs share a conserved "ferrodoxin-like" l3al3l3al3 fold (Arnesano,
2002). This fold motif is also predicted for copper chaperones containing the
GMTCXXC binding site, since a high level of homology exists between these
metallochaperones and the N-MBOs (Huffman, 2001). The solved structures for the
human copper chaperone, Atoxl (Wernimont, 2000), for MNK and WOP and its
yeast homolog, Atxl (Arnesano, 2001a), also exhibit the l3al3l3al3 fold. Figure 4
shows the copper bound MBO2 of MNK in comparison with the copper bound
metallochaperone Atox1.
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Figure 3. Sequence Alignment of the MBOs of WOP
Amino acid sequences of the six N-terminal MBOs of WOP as aligned by conserved
metal binding motif identified above in the boxed region (Genbank protein sequence
accession# P35670 [gil 1703455]. Three missence mutations located within the
MBOs are known which cause Wilson disease to occur. These three mutations
include (G85V) within MBOl, (L492S) within MB05, and (G5910) within MB06.
The conserved glycine and leucine residues involved are underlined above. The
predicted isoelectric points of the MBOs are provided (Huffman, 2001).

Prokaryotic and yeast homologues often have only one or two N-MBOs,
whereas both MNK and WOP each have six. The increased number of MBOs found
in higher species compared to prokaryotes and lower eukaryotes suggest that some of
the MBOs of higher species may serve alternate functions other than transport
activity. The MBOs of MNK and WOP might be differentiated in their functions,
possibly serving to regulate the protein's activity rather than participating in transport
activity or both.
Regulation of MNK and WOP Activity
Several regulatory factors, including copper itself, have been shown to be
associated with the metabolic activities of MNK and WOP affecting such properties
as copper binding, transport, and intracellular protein trafficking. Studies employing
immunohistochemical techniques revealed that both MNK and WOP are localized to

10
Leop I

Loop 2

Figure 4. Conserved l3al3l3al3 Fold Motif Observed in MNK MBDs and
Metallochaperone Atox 1

The NMR solution structure of Cu-MBD2 of MNK is shown above on the left (PDB
entry: lSQU) and the determined crystal structure of the copper bound homodimer of
Atoxl (PDB entry: lFEE) is shown above on the right. Both proteins have been
shown to bind copper in a monomeric bicoordinate manner with two cysteine
residues (Banci, 2004; Anastassopoulou, 2004). The two metal coordinating cysteine
residues are located within loop 1 and the N-terminal end of the first alpha helix for
each protein. Atoxl has also been shown to bind copper in a 3- or 4-coordinate
manner as a homodimer (Wernimont, 2000). The conserved" ferrodoxin-like"
l3al3l3al3 fold motif is also predicted for the MBDs of WDP. Figure 4 was prepared
using RASMOL.
the trans-Golgi network (TGN) under conditions of basal copper concentrations
(Suzuki, 1999). These same studies also showed a reversible copper-induced
trafficking event of both proteins from the TGN to cytoplasmic vesicles (Yamaguchi,
1996). In WDP, trafficking was also accompanied by an increase in copper excretion
to the bile (Hung, 1997).
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During the catalytic cycle ofP-type ATPases an acyl-phosphorylated
intermediate is produced prior to cation transport. In MNK and WDP this catalytic
phosphorylation event is related to protein trafficking, given that it is also a copper
dependent event (Petris, 2002; Vanderwerf, 2001).
The human copper chaperone Atox1 directly interacts with MNK and WDP
for delivery ofcytoplasmic copper to the secretory pathway (Larin, 1999; Hamza,
1999). Furthermore, apo Atoxl has been shown to be capable ofremoving copper
from WDP (Walker, 2002). This signifies that both copper-bound and apo forms of
Atoxl may participate in the regulation ofWDP activity. Recently it has also been
suggested that Atoxl influences the threshold at which copper-dependent events of
MNK take place(Walker, 2002). Atoxl-deficient cells exhibited diminished copper
dependent trafficking ofMNK in comparison to wild type cells (Hamza, 2003).
MNK copper-induced trafficking was restored upon overexpression ofAtoxl or
copper level elevation.
However the most extensively studied area, concerning the regulation of
MNK and WDP activities, may be discerning the role ofthe N-MBDs. Many
different functions have been associated with the N-MBDs ofMNK and WDP.
Several studies have shown that mutations ofthe N-MBDs ofMNK and WDP hinder
their ability to transport copper and rescue the function ofcopper incorporation into
the yeast ceruloplasmin homologue, Fet3, within Ccc2 deficient yeast (Payne, 1998;
Forbes, 1999). These studies illustrate the importance ofthe N-MBDs ofMNK and
WDP for copper translocation.
Moreover, Atoxl reversibly transfers copper specifically to the N-MBDs of
MNK and WDP, revealing that the N-MBDs are essential for interaction with the
copper chaperone as well as copper transport activity (Larin, 1999; Walker, 2002).
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There is evidence that the copper-mediated trafficking ofMNK is associated with its
N-MBDs. Mutations ofthe N-MBDs ofMNK result in inhibition ofintracellular
trafficking suggesting the MBDs may initiate this event through the effects ofcopper
binding (Strausak, 1999). The N-MBDs ofWDP were determined to be responsible
for the cooperative effect ofcopper on catalytic phosphorylation activity (Huster,
2003). While many aspects ofhow the N-MBDs ofMNK and WDP affect copper
transport, catalytic phosphorylation activity, copper chaperone interactions, and
intracellular trafficking ofthe proteins, several issues remain unclear, especially the
specific functions ofthe six N-MBDs.
Role ofthe N-terminal Metal-binding Domains
The precise functions ofthe six N-MBDs ofWDP and MNK are still poorly
understood. In many recent studies the six metal binding sites ofMNK and WDP
were found to be functionally non-equivalent within each protein. What's more,
variations in function between the N-MBDs ofMNK and WDP highlight that
findings for one protein may not be applicable to the other.
Copper Translocation
An example ofthe functional differences between the individual MBDs of
MNK and those ofWDP can be found in their copper transport properties. Yeast
complementation assays have demonstrated that the sixth MBD ofWDP alone is
sufficient for loading copper into Fet3, the yeast homologue ofceruloplasmin (Iida,
1998). A separate study found that the positioning ofthe sixth MBD as the most C
terminal domain could not account for the discrepancy between domains (Forbes,
1999). When the second and third MBDs were mutated in a manner such that their
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position relative to the first transmembrane segment was equivalent to that of the
MBD6 in the wild type, the mutants were still unable to restore copper transport.
This suggests distinct functions for the individual domains of WDP and that the last
two or three most C-terminal domains may be playing a more crucial role in copper
transport.
In contrast to WDP, yeast complementation assays of MNK suggest the third
MBD may play a critical role in copper transport (Payne, 1998). Successive
mutations, beginning with the first MBD, resulted in a sudden termination of copper
transport after the third mutation. However discrepancies have been reported as to
whether the N-MBDs of MNK are even essential for copper translocation.
Mutational studies in mammalian cells involving replacement of the metal
coordinating cysteine residues with serine residues show that copper transport into
the secretory pathway is reduced but still detectable even in the presence of mutated
non-functional N-MBDs (Voskoboinik, 1999).
Copper-mediated Protein Trafficking
Both MBDs five and six were each found to be capable of singly
redistributing WDP in the presence of elevated copper (Cater, 2004). The same study
also reported that the first three MBDs of WDP could not functionally replace MBD5
and MBD6 for copper-induced intracellular protein trafficking. Mutational studies of
the N-MBDs of MNK also report that only the fifth and sixth MBDs are nec(;:ssary for
copper-induced translocation from the TGN to the cytoplasmic vesicles (Strausak,
1999). These studies imply a conserved mechanism may exist between MNK and
WDP regarding copper-mediated intracellular trafficking mechanisms.
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Catalytic Phosphorylation Activity
Phosphorylation of P-type ATPases is contingent on copper binding to the
CPC intramembrane site. Mutations of the N-MBDs of WDP suggest that the fifth
and sixth MBDs play a pivotal role in regulating the protein's phosphorylation
activity by affecting the affinity of the CPC intramembrane site for copper (Huster,
2003). The same studies also noted an increase in the copper dependence for the
phosphorylation of the protein when the first four MBDs were mutated. The author
suggests these first four MBDs may affect availability of copper to the catalytically
important fifth and sixth domains thereby determining the regulating of the protein
turnover. In support of this theory of conformationally mediated interaction, circular
dichroism (CD) spectroscopy data shows that WDP undergoes metal-specific
conformational changes with addition of increasing of amounts of copper (DiDonato,
2000). Another study using the N-terminal model of the rat equivalent of WDP,
showed similar metal-induced secondary and tertiary structural changes (Tsay, 2004).
Atoxl Interaction
Yeast two-hybrid analysis of MNK and WDP interaction with the copper
chaperone Atoxl show variances between the six N-MBDs of each protein (Larin,
1999; Strausak, 2003). For WDP the fifth and sixth MBDs failed to interact with
Atoxl while the first four domains were each capable of independent interaction
(Larin, 1999). More recently, a similar study was conducted examining the
interaction of the individual N-MBDs of MNK with Atoxl (Strausak, 2003)
comparing results obtained from yeast two-hybrid assays to results of surface
plasmon resonance (SPR). It is noteworthy to point out that the yeast two-hybrid
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assay results were similar to those of WDP, with the fifth and sixth MBDs of MNK
failing to show interaction with Atoxl while SPR revealed a copper-dependent
interaction of the chaperone with all six MBDs. A third study using yeast two-hybrid
analysis to examine the interactions between the chaperone Atox 1 and the individual
MBDs of WDP detected copper-dependent interactions between the chaperone with
MBD l , MBD2, and MBD4 with the largest relative strength of the MBD-chaperone
interaction occurring with MBD4 (van Dongen, 2004). Further examination of the
interactions between Atoxl and the individual MBDs of MNK or WDP is still needed
to fully discern the interactions between MNK or WDP and Atoxl . For each yeast
two-hybrid analysis study the MBDs examined were cloned in a unique manner to
differentiate the separate MBDs and determine their interactions. These methods
include (a) mutationally altering the copper coordinating cysteine residues to serine
(Strausak, 2003 ), (b) using deletion constructs (Larin, 1999), and (c) individual
cloning of the MBDs (van Dongen, 2004).
Recent research has also examined whether Atoxl delivers copper to a
preferential MBD of WDP. The transfer of a single copper from the chaperone to the
N-MBD was performed followed by fluorescent labeling with the cysteine-directed
probe 7-diethy lamino-3-(4'-malemeimdylphenyl)-4-methylcoumarin (CPM). Next
the labeled protein was subjected to proteolysis of the N-MBDs and subsequent
amino acid sequencing of the digested fragments (Walker, 2004). Based upon
previous work exhibiting the ability of copper-bound MBDs to selectively protect
their own cysteine residues against labeling by CPM (Lutsenko, 1997), the authors
suggest that MBD2 of WDP preferentially receives copper from Atoxl (Walker,
2004). However since the changes in fluorescent intensities are only offered in a
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qualitative manner and are not actually quantified, the data presented is insufficient to
determine whether MBD2 alone is shielded from CPM labeling.
Further investigations (Walker, 2004) did not display a selective shielding of
the MBDs from CPM labeling when free copper was added to the N-MBDs
indicating the Atoxl may be preferentially delivering copper to specific MBDs within
WDP. Surface labeling experiments yielded similar results with no preferential
copper-binding detected. For determination of whether MBD2 is essential for the
delivery of copper to WDP, site-directed mutagenesis of MBD2's cysteine residues to
alanine was performed and catalytic phosphorylation activity was monitored upon
addition of either copper or Cu-Atox 1. Free copper was able to reactivate catalytic
phosphorylation in both the wild type and the mutant. When copper was delivered
via Atoxl , reactivation of catalytic phosphorylation activity was markedly lower in
the mutant compared to the wild type. The author suggests MBD2 is important to the
copper delivery event from the copper chaperone Atoxl to WDP (Walker, 2004).
Mutational analysis of the other five MBDs of WDP was not performed therefore
their importance regarding copper delivery remains unknown.
Additionally Walker et al. suggests that the copper bound to MBD2 does not
transfer to the other MBDs and thus MBD2 is not acting as the metal loading entry
point for the protein (Walker, 2004). When Cu-MBD2 was exposed to increasing
quantities of the copper-chelator bicinchoninic acid (BCA) of up to 45-fold molar
excess only 10% of copper was removed whereas similar studies conducted with Cu
Atox 1 show a complete loss of copper to BCA. As opposed to a metal loading entry
point role, Walker et al. suggest that copper binding to MBD2 may cause a
conformational shift of WDP subsequently allowing the other MBDs to interact with
Atox 1. These conclusions are founded in the observation that different sized
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fragments ofWDP were generated by trypsin proteolysis after the transfer of a single
copper to the protein therefore copper must cause a conformational change exposing
new sites for trypsin digestion.
Copper Coordination and Exchange
Metal Ion Specificity
Although a high level of sequence similarity exists among P 1 -type ATPases, a
subclass of P-type ATPases transporting heavy metals, numerous studies have shown
these proteins are very selective for the metal ions transported. ZntA is a P1-type
ATPase specific for Pb(II), Zn(II), Cd(II), and Hg(II) containing one GXXCXXC
sequence whereasWDP is specific for Cu(I) and possibly Ag(I) and contains six
repeats of the GXXCXXC motif (Hou, 2001). Previously, the issue of whether the N
terminal metal binding region of ZntA was essential for metal ion discrimination in
the protein was examined using a truncated mutant lacking the amino terminal
domain (Mitra, 2001). The ZntA mutant was still able to confer metal ion specificity
without the presence of the metal binding domain from which the authors concluded
that the transmembrane segments of the protein were primarily responsible for metal
ion recognition.
Additional experiments were conducted using chimeric proteins of ZntA in
which either its N-MBD was replaced with the whole N-terminal domain ofWDP, or
only MBD6 ofWDP (Hou, 2001). The chimeras of ZntA were each able to confer
resistance to lead, zinc, and cadmium salts but not copper salts. Both chimeras also
displayed ATPase activity in the presence of lead, zinc, cadmium, and mercury, all of
which are ZntA substrates, but none such activity was detected for copper or silver,
the metal substrates ofWDP.
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While the truncated mutants and chimeras of ZntA both retained metal ion
specificity, a reduction in ATPase activity compared to wild type ZntA was observed
for each case (Hou, 2001). These results suggest that replacing the N-terminal domain
of ZntA may not alter the protein's metal specificity determined by the
transmembrane segment and also that the N-MBD interacts with the rest of the
transporter in a metal ion-specific manner (Hou, 2001).
Immobilized metal affinity chromatography (IMAC) analysis of the amino
terminal domain of WDP revealed its varying affinities for different metals to be as
follows: Cu(II)>>Zn(Il)>Ni(II)>Co(II) (DiDonato, 1997). The metal binding
properties were further examined in the same study with a zinc blotting assay. The
amino-terminal domain was found to bind Zn(II) and in competition with Zn only
Cd(II), Au(III) and Hg(II) were able to reduce the quantity of Zn(Il)-protein complex.
In similar studies using Cu (II) and Cu (I) as the competitor much lower
concentrations of copper were needed to decrease Zn(II) binding. Additionally when
the concentration was increased above a 10 µM threshold Zn(II) binding reduced
drastically, suggestive of a cooperative binding mechanism. Another study found that
Zn bound to the N-terminal domain of WDP is ligated primarily to nitrogen atoms
unlike the sulfur ligands of cysteine which are involved in copper coordination
(DiDonato, 2002). Conformational changes occur in WDP both upon binding of zinc
and copper, however these changes are significantly different for each metal causing
a loss of secondary structure in zinc, suggesting a plausible structure-based
mechanism of the N-terminal domain for the discrimination of different metal ions in
vivo (DiDonato, 2002).
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Copper Binding
Copper maximally binds both MNK and WDP with a stoichiometry of six
metal ions per protein in the reduced Cu(I) form such that each MBD is coordinated
with copper in a 1:1 fashion (Lutsenko, 1997; Cobine, 2000). For determination of
the oxidation state of copper bound to MNK and WDP, the proteins were denatured
and assayed with bicinchoninic acid (BCA), a Cu(I)-selective chelator. The BCA
based assay was performed in the presence and absence of a reducing agent,
ascorbate. Addition of ascorbate did not significantly alter the absorbance obtained
using the BCA-based assay indicating the copper released from the protein was
already in a reduced state as Cu(I). Additionally the BCA-based assay was used to
determine the quantity of copper-bound to protein; increased quantities of copper
were bound with the presence of ascorbate in the growth media (Lutsenko, 1997).
Further examination of the oxidation state of copper complexed to WDP has
been performed using XAS (x-ray absorption spectroscopy) analysis (DiDonato,
2000). EXAFS (extended x-ray absorption fine structure) data indicates that each
copper atom is ligated via two sulfur atoms both with a Cu-S distance of 2.17A.
These results are similar to the Cu-S bond distance observed in MNK (Cobine, 2000;
Ralle, 1998). The Cu-S of 2.17 A is between distances observed for trigonal and
linear Cu (I)-thiolate complexes suggesting that copper is coordinated by two
cysteines in a distorted linear geometry. By contrast, the crystal structure of the
copper chaperone Atox1 reveals Cu(I) ion is ligated to two separate Atox1 molecules
in a distorted tetrahedral geometry with three Cu-S distances of 2.3 A and a fourth of
2.4 A suggesting that copper may be either 3- or 4-coordinate (Rosenzweig, 2001).
The monomer of the copper chaperone Atoxl was recently determined to bind copper
in a 2-coordinate manner as determined by the NMR solution structure
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(Anastassopoulou, 2004). The NMR solution structure of Cu(I) bound MNK MBD2
determined the ligand donating cysteines residues of the MBD were situated between
the first 13 strand and the first a helix, a location close to the protein surface in a
solvent accessible manner, and the S-Cu-S bond angle formed was 140° ± 40° (Banci,
2004). Through comparison with the apo form ofMNK MBD2 the cysteine
containing loop was observed to undergo the most structural changes upon copper
binding. The structure ofMNK MBD2 is similar to other MBD structures of P-type
ATPases and some copper chaperones, specifically the first MBD of the yeast
homologue Ccc2 (Banci, 2001), Atxl (an Atoxl yeast homologue) (Arnesano, 2001a)
and MNK MBD4 (Gitschier, 1998).
XANES spectra of WDP showed a conserved peak at 8983 eV with varying
stoichiometric concentrations of copper to protein (DiDonato, 2000). This peak is
consistent with the l s._ 4p transition of a Cu(I) center (DiDonato, 2000) as
confirmed in the Cu(I)-thiolate model complexes [Cu(SC10H13)2r and [Cu(SC6Hs)3r.
This data clearly demonstrates that Cu bound to WDP is in the +1 oxidation state, and
also that the metal binding coordination of the individual MBDs are quite similar to
each other. The intensity of the transition at 8983 eV, which is indicative of the
geometry around the Cu atom, is weaker than that of linear Cu-thiolate complexes,
but stronger than that of trigonal compounds.
CD spectroscopy studies show progressive changes in the secondary and
tertiary structure of WDP as the copper concentration is elevated (DiDonato, 2000).
Secondary structure changes are evident in the increasingly negative molar ellipticity
values measured at 208 nm and 222 nm indicative of an increase in helicity as copper
is added to the protein. For the tertiary structure the aromatic region displays changes
in magnitude and a loss of ellipticity at 330 nm, representing a loss of disulfide
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bonds, as copper concentration increases. The combined CD and XAS data implicate
that the binding environments surrounding the copper atoms remain unchanged
during successive binding of copper while structural changes occur in the protein.
The rat homologue of WDP, designated rCBD, shares 80% homology with
WDP yet contains only five repeats of the metal binding motif CXXC with the fourth
MBD relative to WDP absent (Tsay, 2004). Recently, through structural homology
modeling, the fourth MBD was identified within rCBD and showed the conserved
f3af3f3af3 fold characteristic of the MBDS (Tsay, 2004). Zn blotting assays reveal
rCBD performs cooperative copper binding and metal ion discrimination similar to
WDP. Comparisons of CD data for rCBD and WDP show the two proteins both
undergo similar conformational changes upon addition of copper. Interestingly, the
cooperative copper binding behavior of rCBD seems to be quite comparable to that of
WDP despite the absence of one CXXC motif in the fourth "metal binding domain"
signifying the importance of the f3af3f3af3 fold in this metal binding and the
subsequent conformational changes of the protein. The CXXC motif does appear to
be necessary for Cu(I) coordination however since rCBD was capable of binding only
five equivalents of copper (Tsay, 2004).
Binding Affinities and Copper Exchange
Recent studies have examined the MBDs of WDP regarding their affinity for
Cu(I) (Wernimont, 2004). Although all six MBDs of WDP have been shown to be
capable of binding copper (DiDonato, 1997), if different affinities for copper existed
between the domains this would affect their roles in copper transport and copper
mediated events such as protein trafficking. Isothermal titration calorimetry (ITC)
was used to measure the association constants (Ka) and stoichiometry (n) of Cu(I)
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binding to the WDP MBDs (Wernimont, 2004). The association constants for all the
MBDs and Atox1 were reported to be ~105 - 106 M" 1 determining that the copper
affinities of the MBDs are not responsible for their nonequivalent functionalities.
However, the same study reported a higher binding affinity for the linked multi
domain protein MBD1-4 over the individual MBDs. These results indicate the
affinity of the MBDs for copper may be influenced by the presence of other MBDs.
The multi-domain product MBDl-6 was found to have an affinity for copper similar
to the individual MBDs and Atoxl (Wernimont, 2004).
Copper exchange studies between the yeast proteins Ctrl and Ccc2 as well as
Ccc2 and Atx1 have provided insight into the mechanism of copper transfer by the
MBDs and interacting proteins (Xiao, 2004; Huffman, 2000). The transfer of copper
between the first MBD of Ccc2 (Ccc2a) and Atxl has been examined using NMR
titrations (Arnesano, 2001b). By monitoring the titrations of 15N-labeled Cu(l)-Atxl
with the apo-Ccc2a MBD and 15N-labeled Cu(I)-Ccc2a MBD with apo-Atx l
Arnesano et al. determined the two proteins were interacting and forming a transient
protein-protein complex. The NMR data showed single signals for each labeled
protein nucleus during the titrations. The chemical shift changes detected during the
titrations were found to be dependent upon the quantity of unlabeled protein titrated.
Furthermore, the apo and metal bound forms of the proteins exhibited distinct NH
chemical changes between the free and compiex states. Arnesano et al. concluded
these results were consistent with a rapid exchange occurring between the free protein
and protein-protein complex states. A mechanism for Cu(I) transfer between Atxl
and Ccc2a was proposed based upon the x-ray crystal structures of the proteins and
NMR titration data. The mechanism is depicted in Figure 5. Copper exchange is
mediated through the positioning of the two proteins by electrostatic forces. Next
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Cys of Cu-Atxl , the most solvent exposed copper ligand, interacts with Ccc2a
forming a protein-protein complex. As a result of complex formation Cys ts
undergoes a conformational change. While the protein-protein complex is formed
copper is quickly partitioned between the two proteins forming 2- and 3-coordinate
intermediates with the proteins. The observed conformational changes between apo
and Cu(I) bound states were greater for apo Atx 1 than apo Ccc2a with the significant
shifts occurring in loops 1 and 5 and helices a l and a2. These regions are the nearest
to the metal-binding site with loop 1 containing the metal-binding motif GMTCXXC.
The mobility of apo Atx 1 in these regions could favor dissociation of the chaperone
from the complex.
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Figure 5. Proposed Mechanism for Cu(I) Exchange Between Atxl and Ccc2a Using
Ligand Exchange Reactions
Additionally the copper exchange between Atxl and Ccc2a was studied in
regards to understanding whether the reaction occurred under kinetic or
thermodynamic control (Huffman, 2000). Similar to the findings by NMR titration
the copper exchange was determined to reach equilibrium quite rapidly. Kinetic
control of the reaction was suggested since only a small thermodynamic gradient was
observed upon copper exchange between Atxl and Ccc2, ~0.2 kcal/mol (Kexchange =
1.4 ± 0.2). Upon consideration of the quantity of free copper within the cell,

estimated at less than 10-18M (Rae, 1999), and the associated high capacity for copper
chelation, one proposed mechanism for chaperone to maintain its specificity is via a
slow kinetic rate constant, koff, allowing the chaperone to retain copper despite the
cellular environment (Wernimont, 2004). The complexation event between the
chaperone and donor could alter koff, reducing the kinetic activation barrier, and
allowing copper exchange to occur. Recently another study involving copper
exchange investigated dissociation constants of Cu(I) binding for the yeast proteins
Ctr1, Ccc2, and Atxl. The experiments were conducted using the copper binding
competitor bathocuproine disulfonate (BCS). BCS forms a stable copper complex
with a known absorption coefficient and an overall association constant of 10 19·8 for
the species Cu1(bcs)23 - (Xiao, 2004). The change in absorbance was measured as
copper was transferred from BCS to the protein of interest. The dissociation
constants were estimated to be ~10 19 M, demonstrating the ability of these proteins
to acquire copper under limiting conditions (Xiao,2004).
Significance of This Study
Few of the MBDs of either MNK or WDP have been independently
expressed, purified, and characterized. Within WDP, three missence mutations of the
N-terminal MBDs are known which result in Wilson disease, G85V (MBD l ), L492S
(MBD5), and G591D (MBD6). Comparison of the G85V mutant and wild type
MBD1 could provide significant insight how a glycine - valine mutation within a
single domain produces the disease state.
The similarity in secondary structure between the MBDs of MNK and WDP
and the copper chaperone Atox1 in combination with the differences in electrostatic
surface properties of these domains indicates a potential for domain-domain
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interactions to occur. If present, these domain-domain interactions within the amino
terminal of the ATPase would represent an unexplored avenue of protein regulation.
The fourth metal-binding domain of WDP was selected as a potential candidate for
copper transfer with MBD 1. The reasoning for this selection was based upon the
predicted isoelectric points for the two domains being several pH units apart as
MBD4 is considered the most acidic of the six MBDs.
Objectives of This Study
The goal of this study was to characterize domains one and four of the N
terminal metal binding domain of WDP and the disease-causing missence mutation of
domain one, G85V. The domains were each cloned into an E. coli expression system,
produced, and purified. The purified proteins, MBDl and MBD4, were each
characterized through means of high resolution gel filtration, MALDI mass
spectrometry, and isoelectric focusing. Furthermore the abilities of each individual
domain to bind copper and reversibly transfer the metal to the other domain were
investigated. The copper exchange studies were performed at near physiological
concentrations of copper in the range of 8-20µM within an anaerobic environment.
The affect of varying molar ratios between the copper donor and acceptor was
examined. The Kexchange constant was calculated for the reaction. Separation of the
proteins was achieved after copper exchange using strong anion exchange
chromatography. The copper content of each protein after the exchange was
determined using ICP-MS analysis.
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CHAPTER II
MATERIALS AND METHODS
A plasmid containing the full-length human ATP7B gene was generously
donated by Dr. Jonathon Gitlin of the University of Washington at St. Louis.
Cloning of WDP MBDs into E. Coli Expression Vectors
Primer design for metal-binding domains one and four of WDP was based
upon the ATP7B gene sequence obtained from GenBank accession# U03464.
MBDl was amplified using forward primer 5'-CCT GGG CCC TTC TTC CAT GGT
GGC CAC-3' and reverse primer: 5'-AGA AGG ATA GGC AGG ATC CTG GCC
CTC AAG-3'. Likewise MBD4 was generated using forward primer: 5'-CGA GAA
ACC AGG CCA TGG GCA CAT GCA G-3' and reverse primer: 5'-GTT TCC AAG
AGG GAT CCT AGA ACA GCT TTC-3'. Primers were designed to incorporate an
Nco I restriction site at the 5'-end and a BamH I restriction site at the 3'-end of the
MBDs for directional cloning into expression vectors. The template DNA provided
by Dr. J. Gitlin was used in the PCR reaction.
The PCR reactions each included the following: 5 µL DNA template (0.2
ng/µL), 0.6 µL Deep Vent DNA Polymerase (2 U/µL) from New England Biolabs, 5
µL of each forward and reverse primers (10 µM stock), 5 mL dNTP mix (2 mM
stock), 5 µL l 0x reaction buffer, and 24.4 µL reverse osmosis H20. Each PCR
reaction was covered with 30 µL of mineral oil. For MBDl the thermal cycling
conditions were as following: one cycle of (a) 100°C for 5 minutes, (b) 63°C for 1
minute, (c) 72°C for 30 seconds, followed by twenty-nine cycles of (a) 100°C for 1
minute, (b) 63°C for 1 minute, (c) 72°C for 30 seconds. For MBD4 the thermal
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cycling conditions were the same as those detailed for MBD1, with the exception of
the temperature setting ofstep (b) being 57 °C as opposed to 63°C for each cycle. The
PCR products were verified by 1.8% agarose gel.
The MBD PCR products and the ampicillin resistant plasmid vector pET-21d
(Novagen) were each digested with BamHI and Neal (6 enzyme units each) for 4
hours at 37°C. Following digestion both the MBD PCR products and plasmid digests
were purified using QIAquick PCR Purification Kit (Qiagen). After purification
ligation reactions were constructed for insertion ofthe MBD genes into the plasmid
vectors. For each MBD, three ligation reactions were prepared with varying molar
ratios ofMBD to plasmid vector (1:3, 1:1, and 3:1). Each 20 µL ligation reaction
consisted of200 ng plasmid, 2 µL l0x reaction buffer, 0.4 µL T4 DNA ligase (400
units/µL), varying concentrations ofdomains one or four, and reverse osmosis H20
for final volume adjustment.
Each ligation reaction was incubated at 18°C for 4 hours and then transformed
as detailed into competent E. coli DH5a cells. A 200 µL aliquot ofcompetent cells
was thawed on ice. 3 µL DMSO were added to the cells, mixed gently, and then the
cells were incubated on ice for 30 minutes. The cells were heat shocked for 2 minutes
at 42°C then incubated on ice for 2 minutes. Next 1 mL Luria Bertani (LB) media
was added and the reaction was incubated at 37 °C for 1 hour shaking at 250 rpm.
The transformed DH5a cells were subsequently grown on LB agar media containing
100 µg/mL ofthe antibiotic ampicillin for 16-20 hours at 37 °C
Colonies ofDH5a cells were screened for the presence ofrecombinant
plasmid using restrictive digestion analysis with the endonucleases Bglll and BamHI.
Colonies were first inoculated into 5 mL ofLB and incubated at 37 °C with shaking at
250 rpm overnight. The plasmids were isolated from bacterial culture using QIAprep
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Mini Spin Kit and then digested with Bgl II and BamH I at 37 C for 4 hours to verify
the ligation success. Once verified by restrictive digestion the recombinant plasmids
were submitted for sequence analysis to Dr. Todd Barkman's lab, of the Biology
Department at Western Michigan University.
Mutagenesis of Domain One
The mutated domain one was prepared using Stratagene's Quikchange XL
site-directed mutagenesis kit. Mutagenic primers were designed to incorporate the
G85V mutation. The sequence of the forward primer was: 5' - GGA TTT CCA ATT
TGA AAG TCA TCA ACA GCA TGA AGG TTT CC-3' and the reverse primer
sequence was: 5'-GGA AAC CTT CAT GCT GTT GAT GAC TTT CAA ATT GGA
AAT CC-3'. The mutated domain was amplified using PCR. The PCR mixture
included 5 µL of 1Ox reaction buffer, 1 µL dNTP mix, 3 µL Quik solution, 5 µL each
of forward and reverse primer (2 µM), 0.35 µL of template plasmid (10 ng), and
30.7 µL of reverse osmosis H20. After addition of 1 µL of pFu Turbo DNA
polymerase the reaction was covered with 30 µL of mineral oil. The PCR thermal
cycling parameters consisted of 1 min at 95°C, followed by 18 cycles of: 95°C for 50
seconds, 60°C for 50 seconds, 68°C for 7 minutes. After 18 cycles were completed
the reaction was stored at 4°C. The parental DNA of the PCR reaction was
selectively digested with 1 µL Dpnl (10 u/µl) at 37°C for 60 minutes.
The mutated plasmid was then transformed into XL-10 Ultracompetent cells.
A 45 µL aliquot of cells was thawed on ice. Next 2 µL �-mercaptoethanol were added
to the cells, mixed gently, and then the cells were incubated on ice for 10 minutes.
Once the mineral oil layer was removed 2 µL of Dpnl digest were added to the cells.
The transformation reaction was mixed gently and incubated on ice for 30 minutes.
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The cells were heat shocked for 30 seconds at 42 C then incubated on ice for 2
minutes. Next 500 µL pre-warmed LB media were added and the reaction was
incubated at 37 °C for 1 hour shaking 250 rpm. The cells were plated onto LB agar
plates containing 100 µg/mL ampicillin and incubated inverted overnight at 37 °C.
Colonies from the XL-10 transformation were inoculated into 5 mL cultures of LB
media containing 100 µg/mL ampicillin and incubated at 37°C overnight shaking at
250 rpm. The plasmids were isolated from bacterial culture using QIAprep Mini Spin
Kit. The isolated plasmid was run on a 1.2% agarose gel to determine the
concentration and then submitted for sequence analysis.
Protein Expression Optimization
Prior to large scale protein production using 10 L cultures, time-course
induction experiments were performed in 5 mL volumes to determine optimum
conditions. Initially proteins were expressed in the E. coli strain BL21 (DE3) through
the addition of the inducing agent isopropyl-1-thio-�-D-galactopyranoside (IPTG). A
single colony of BL21(DE3) cells containing the recombinant plasmid was inoculated
into 5 mL LB with 100 µg/mL ampicillin and incubated at 250 rpm, 37 °C until the
optical density at 600 nm (OD6oo) was approximately 0.600 (0.45-0.65). A 500 µL
background level aliquot was then collected, the OD6oo recorded, and finally
centrifuged for 2 minutes. The cellular pellet was stored at -20° C until ready for
SDS-PAGE analysis. Upon reaching the desired OD600 value, protein expression was
induced with the introduction of 1.0 mM IPTG into the growth media. The induced
bacterial culture was incubated at 250 rpm, 37 °C for up to four hours. During this
incubation 500 µL aliquots were collected every 30-60 minutes; each collected
sample was treated as previously described for the background aliquot. Efficiency of
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the protein expression was monitored by SDS-PAGE using 15% polyacrylamide 1 M
Tris gels where the loading volumes for each aliquot were normalized against the
background aliquot of 500 µL culture collected prior to IPTG induction.
Optimization studies of protein overexpression were performed by varying
several factors including cell growth conditions, E. coli expression hosts, and
induction parameters. To decrease loss of protein expression due to the possibility of
a toxic eukaryotic gene product being encoded in an E. coli host, the Toxic Gene
Induction protocol from Novagen was followed. Both the wild type and the G85V
mutant of MBD 1 were evaluated.
A single colony was inoculated into 2 mL Terrific Broth (TB) media
containing 200 µg/mL carbenicillin and incubated at 37°C, 250 rpm until OD600 ~ 0.4.
The cells were collected by centrifugation for 30 seconds, the supernatant removed,
and the pellet resuspended in 2 mL fresh TB media. Next, 100 µl of resuspension
was added to 8 mL TB media containing 500 µg/mL carbenicillin and incubated at
37°C until OD600 ~ 0.4. A 500 µL aliquot was collected as the background sample,
and the pellet was stored at -20°C. The cells were collected by centrifugation at 1000
x g for 5 minutes and resuspended in 5 rnL fresh TB media containing 500 µg/rnL
with 1 mM IPTG and incubated for 2 hours at 37 °C, 250 rpm. An aliquot was collect
in the same manner as the background sample after 2 hours. The samples collected
were run on 15% Tris SDS-PAGE for analysis.
The effect of incubation temperature on the protein expression was studied
both at 30°C and 37 °C. Studies were conducted in two different ways. The first set
of studies altered the temperature only after the addition of IPTG and onset of target
protein expression and the initial incubation temperatures after inoculation were kept
at 37 °C. The second set of studies were conducted at a single temperature, either
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30 C or 37 C, from inoculation until completion of the experiment. Temperature
variance expression studies were conducted in LB and TB media. Attempts at
examining expression in minimal media were not completed as> 12 hours were
required to meet the necessary OD6oo (0.45-0.65) for induction.
The effect of growth media on protein expression levels was also examined.
MBD1 wild type, MBD 1 G85V mutant, and MBD4 were each expressed in LB, TB,
and minimal bacterial culture media. Each study included inoculating colonies into 5
mL of media containing l00µg/mL ampicillin and incubating until the cells' OD600
was within 0.45-0.65. At this point a 500 µL aliquot was collected, with recorded
OD600, and centrifuged for 2 minutes. The pellet was stored at -20°C until ready for
SOS-PAGE analysis. The remaining culture was induced with 1mM IPTG and
incubated for 2-4 hours at 37°C with 250 rpm shaking. Every 30 minutes an aliquot
was collected, OD measured, centrifuged, and stored at -20°C. Again SOS-PAGE
analysis was used to determine protein expression levels. The growth media
experiments were also conducted with 1% glucose supplementation.
In addition to testing multiple media for optimization of protein expression,
the use of rare codons in the protein nucleotide sequence was examined. Rosetta
(DE3) cells (Novagen), derived from the BL21(DE3) E. coli strain, contain the genes
to encode for several t-RNAs which are least abundant in E. coli yet commonly
present in eukaryotic genes: AUA, AGG, AGA, CUA, CCC, and GGA. The
recombinant plasmids containing the cloned MBDs were each transformed into
competent Rosetta (DE3) cells. 20 µL aliquots of cells were thawed on ice for 5
minutes. 10 ng of plasmid DNA was added to the cells and incubated on ice for 5
minutes. The cells were heat shocked at 42°C for 30 seconds and then incubated on
ice for 2 minutes. 80 µL of SOC media was added to the transformation reaction and
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the tubes were incubated at 37 C with 250 rpm shaking for 1 hour. The reaction was
subsequently plated onto LB agar plates containing 100 µg/mL ampicillin and
incubated inverted at 37 °C overnight. Expression studies previously conducted using
LB, TB, and minimal media were each repeated in combination with altering the
incubation temperature, using the Rosetta cells as the E. coli host.
The initial plasmid vector, pET-2l d (Novagen), selected for cloning of the
MBDs was an ampicillin resistant T7 RNA polymerase based plasmid. The genes
for MBD1 wild type, MBD1 G85V mutant, and MBD4 were each cloned into the
plasmid vector pET-24d (Novagen) which is different from the previous vector pET21d only in its antibiotic resistance to kanamycin rather than ampicillin. Individual
recombinant pET-21d plasmids containing MBDl, MBDl G85V mutant, or MBD4
were digested with Nco I and BamH I at 37°C for 4 hours. The excised genes for the
MBDs were purified from the digest using the QIAquick Gel Extraction Kit (Qiagen)
after digest reactions were run on a 1.8% TBE agarose gel. pET-24d was also
digested with the enzymes Nco I and BamH I under the same conditions. The
plasmid digest was purified with the QIAquick PCR Purification Kit and
subsequently ligated with the isolated MBD gene inserts. Conditions of the ligation
reactions were the same as previously used when cloning the genes into pET-21d.
The recombinant pET-24d plasmids were each transformed into Rosetta E. coli cells
for further protein expression studies.
Lastly, optimization studies were conducted investigating the effects of IPTG
concentration upon protein expression levels. Several experiments were performed
on the recombinant pET-24d plasmid containing MBDl using Rosetta cells as the E.
coli expression host where IPTG concentrations ranged from 0.1 mM-2.0 mM. In

addition to altering IPTG concentrations, the use of glucose supplementation,
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different culture media, and incubation temperatures were also tested. Based upon
results ofMBD1 expression during these experiments MBD1 G85V and MBD4
expression levels were studied using LB and TB media at 30°C and 37°C using IPTG
concentrations of0.3 mM, 0.5 mM, 0.7 mM, and 1.0 mM.
Protein Expression and Purification

10 L Induction
A 10 L induction ofboth MBDl and MBD4 was performed prior to
purification ofthe proteins. A single colony was inoculated into 5 mL ofLB media
containing 30 µg/mL kanamycin and incubated at 37°C until OD600 reached 0.6. The
cells were collected by centrifugation, 6000 rpm x 8 minutes using a Sorvall RC-SB+
centrifuge with S S-34 rotor. The cells were resuspended in 250 mL fresh LB media
and 30 µg/mL kanamycin and incubated at 37°C until OD600 reached 0.6. The cells
were collected by centrifugation, 6000 rpm x 8 minutes using a Sorvall RC-SB+
centrifuge with SLA-3000 rotor. The bacterial pellet was next resuspended in 10 L
fresh LB media containing 30 µg/mL kanamycin. The culture was incubated at 37°C
using a New Brunswick Microferm Fermentor with 500 rpm stirring and aeration of
10 psi until OD600 reached 0.6. An un-induced aliquot of 1 mL was collected for
SDS-PAGE analysis. Protein overexpression was induced with addition ofIPTG,
final concentration, 0.5 mM. The cells were incubated at 37°C for 2 hours after IPTG
induction, then harvested by centrifugation (6000 rpm x 8 minutes) in the same
manner as before. Prior to centrifugation an induced aliquot of 1 mL was collected
for SDS-PAGE analysis.
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Freeze/Thaw Extraction of Protein
The bacterial cell pellets were frozen in liquid nitrogen for 10 minutes then
thawed at room temperature for 40 minutes, this cycle was repeated two more times.
The thawed pellet was resuspended in extraction buffer (20 rnM MES/Na, 1 rnM
EOTA, 5 rnM OTT, pH 6.0) using 24 ml buffer/ L cultured media. The suspension
was gently shaken on ice for 1 hour. After incubation on ice the suspension was
centrifuged for 15 minutes x 6000g at 4°C using a Sorvall RC-5B+ centrifuge with
SLA-3000 rotor. The supernatant (containing protein) was collected for further
purification. A 50 µL aliquot was collected for Bradford assay and SOS-PAGE
analysis. The freeze thaw extraction treatment used selectively releases soluble
cytoplasmic E. coli and recombinant proteins of less than 30 kOa in size through
disruption of the outer cellular membrane and formation of pores within the
cytoplasmic membrane (Johnson, 1994; Morris, 1993).
Batch Absorption Anion Exchange Chromatography
Crude MBO1 protein extract was first purified using a batch absorption anion
exchange technique prior to loading the protein filtrate onto a cation exchange
column. OEAE-Sepharose Fast-Flow resin (Amersham Pharmacia Biotech) was
equilibrated in 20 rnM MES/Na, 0.1 rnM EOTA, 5 rnM OTT, pH 5.5 by stirring
gently for 30 minutes. The protein extraction was added to the resin and stirred for
30 minutes. The resin was allowed to settle and the supernatant was collected
through a Buchner funnel using a Whatman #41 filter. A 50 µL aliquot of the
MBOl -containing filtrate was collected for Bradford assay and SOS-PAGE analysis.
The flow-through was then filtered with a 0.22µm filter before loading onto the FPLC
for further purification. For removal of ionically-bound proteins, the OEAE resin
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was resuspended in high salt buffer, 20 mM MES/Na, 0.1 mM EDTA, 5 mM DTT, 1
M NaCl, pH 5.5 and stirred for 30 minutes. The resin was allowed to settle and
filtered through a Buchner funnel. An aliquot of the high salt filtrate was collected
for Bradford assay and SDS-PAGE analysis.
Ion Exchange Chromatography Employing FPLC
An Amersham Pharmacia Biotech AKTA Design FPLC system was employed
for all column chromatography techniques described hereafter. The FPLC system
used is capable of monitoring the ultraviolet absorbance at 254 nm or 280 nm during
sample fraction elution. Absorbance was selected to be monitored at 254 nm as the
absorbance peaks were amplified over those measured at 280 nm due to the low
quantity of aromatic residues present in either protein responsible for A2so (amino
acid sequences are presented in Figure 3). CM-Sepharose Fast-Flow resin was
employed for ion exchange purification of MBD l whereas DEAE-Sepharose Fast
Flow resin was used for MBD4. Each chromatography column was packed with
degassed resin at a rate of 2.5 mL/min to yield a total column volume of
approximately 80 mL. Prior to protein loading each column was equilibrated with
low salt buffer, (20 mM MES/Na, 0.1 mM EDTA, 5 mM DTT, pH 5.5) using four
column volumes at a flow rate of 2.0 mL/min. The filtered protein samples were each
loaded onto the columns at a flow rate of 2.0 mL/min. During sample loading the
column flow-through was collected and labeled as Fraction A. The columns were
then re-equilibrated with the low salt buffer for removal of any unbound protein using
2 column volumes of low salt buffer; the flow-through collected was labeled as
Fraction B. A salt-gradient was next applied over three column volumes, increasing
the salt concentration from initially 0% of high salt buffer (20 mM MES/Na, 0.1 mM
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EDTA, 5 mM DTT, IM NaCl, pH 5.5,) to a final concentration of 50%. The salt
gradient eluants were collected in 3.3 mL fractions, 95 fractions were collected
altogether. In conjunction with the UV absorbance recorded during the ion exchange
Bradford assays were performed on every third fraction within to determine where
the protein eluted. SDS-PAGE analysis was performed on fractions with higher
Bradford readings. Samples with protein present were combined and concentrated to
a volume of approximately 2.0 rnL using a 60 mL Amicon Ultra-filtration cell.
Gel Filtration
Gel filtration was used to further purify the protein by size exclusion.
Superdex 75 prep grade resin packed in a 26/60 column (Amersham Pharmacia
Biotech) with an approximate column volume of 330 rnL was used. After removal of
the 20% ethanol storage solution using 2 column volumes reverse osmosis H 20 the
column was equilibrated using a buffer containing 20 mM MES/Na, 10 mM DTT,
150 mM NaCl, pH 6.0. The protein-containing sample was loaded into a pre-washed
syringe, and then injected into the 2.2 ml injection loop. Prior to sample injection the
column was briefly re-equilibrated with 0.1 column volumes. Fractions of 5.1 mL
were collected for 1.5 column volumes, 95 fractions were collected in total. Bradford
assays were performed on every third fraction within the absorbance peak containing
range to determine target protein containing eluants. SDS-PAGE analysis was
performed for verification of Bradford assay results.
Protein Quantification
Several methods were employed to verify the purity, mass, and concentration
of the purified proteins. Amino acid hydrolysis was performed on both MBDs by the

37
Texas A&M University Protein Chemistry Laboratory for determination of protein
amino acid composition and furthermore for quantification of the molar
concentrations for each protein solution. Matrix Assisted Laser Desorption
Ionization time-of-flight (MALDI TOF) mass spectrometry was also utilized as a
means to verify purity as well as determine the molecular mass of the isolated
proteins. Based upon the amino acid hydrolysis established protein concentrations, a
Bradford assay (Bio-Rad) standard curve was constructed for each protein. The
Bradford assay is based upon the shift in absorbance that occurs when Coomassie
Brilliant Blue binds to the arginine and aromatic residues of proteins in solution
causing the dye to turn from a red to blue color (Bradford; 1976); the absorbance is
measured at 595 nm for the assay.
Additionally protein concentrations were determined by using a Thiol and
Sulfide Quantitation Kit (Molecular Probes). The concentration of thiols in each
protein can be attributed to the cysteines residues, of which 4 are present in MBD1
and 3 in MBD4. The method employed for thiol quantitation was a modified
Ellman's assay utilizing the enzyme papain for increased sensitivity. Ellman's assay
is a spectrophotometric method for determining thiol concentrations (Ellman, 1959).
The assay is based upon the reaction of Ellman's reagent [5,5 '-dithiobis(2nitrobenzoic acid), DTNB] to form a disulfide bond with the thiols of the sample.
The stoichiometric formation of the yellow colored product, TNB thiolate (5-thio-2f

nitrobenzoate, TNf ), can be measured at 412 nm. The thiol concentration of the
f

sample can calculated using Beers Law and the extinction coefficient of TNf . The
reactivation of the enzyme papain by thiols provides an assay with a 100-fold
increased sensitivity for thiols over Ellman's assay (Singh, 1993). The reactivated
papain is quantitated by its enzymatic activity with the substrate N-benzoyl-L-
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arginine-p-nitroanilide; the amount of chromogenic p-nitroaniline generated through
enzymatic cleavage of the substrate can be measured by absorbance at 410 nm.
Isoelectric Focusing
The isoelectric focusing of all the purified MBDs of WDP recently produced
(MBDl , MBD3, MBD4, MBD6, and MBD5-6) in the laboratory of Dr. David
Huffman was accomplished using pH 3-9 gradient gels maintained at l 5°C on a
Pharmacia PhastSystem separation unit. The IEF program consisted of three steps:
pre-focusing, sample application, and focusing. The programmed parameters for
each step are detailed as follows: pre-focusing at 2000 V, 2.5 mA, 3.5 W for 75 volt
hours, sample application at 200 V, 2.5 mA, 3.5 W for 15 volt hours, and focusing at
2000 V, 2.5 mA, 3.5 W for 410 volt hours. For each protein approximately 1 µg was
used for analysis. For isoelectric point determination the Broad Range pl Calibration
Kit from Amersham Pharmacia Biotech was used. Staining of the IEF gels was
performed manually and consisted of four steps: (a) fixing the gel at room
temperature for 10 min. with 20% trichloroacetic acid, (b) rinsing at room
temperature for 2 min. using a 10% acetic acid, 30% methanol solution, (c) staining
at 50°C for 20 min. with a 0.02% Coomassie Brilliant Blue, 0.1% copper(Il)sulfate,
10% acetic acid, 30% methanol solution, and (d) destaining at 50°C for 30 min. with
a 10% acetic acid, 30% methanol solution.
High Resolution Gel Filtration
High resolution gel filtration was used to broadly characterize the proteins for
molecular mass properties. Two columns, Superdex 75 10/30 HR and Superdex
Peptide HR 10/30 (Amersham Pharmacia Biotech), were employed to provide a
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better estimate of protein mass. The Superdex 10/30 HR column was calibrated with
the following molecular mass standards: ovalbumin (43,000 Da), chymotrypsinogen
A (25,000 Da), ribonuclease A (13,700), and bovine serum albumin (7,000 Da). The
column -void volume was determined using blue dextran. Purified proteins of MBD1,
MBD5, and MBD5-6 of WDP were each loaded onto the Superdex 10/30 HR
column and eluted with 20 mM MES/Na, 10 mM DTT, 150 mM NaCl, pH 6.0 at a
flow rate of 0.5 mL/min. Collected fractions of 0.5 mL were analyzed for protein
content using SDS-PAGE. For molecular mass calibration of the Superdex Peptide
10/30 HR column the following standards were used: myoglobin (17,800 Da),
ribonuclease A (13, 700 Da), cytochrome c (12,500 Da), aprotinin (6,500 Da), gastrin
I (2,126 Da), vitamin B 12 (1,355 Da), (glycine)6 (360 Da), (glycine)3 (189 Da), and
glycine (75 Da). As before, blue dextran was used to calculate the column void
volume. Proteins of metal-binding domains 1, 4, 6, and 5-6 were each loaded onto
the Superdex Peptide 10/30 HR column. Each protein was eluted from the column
with 20 mM phosphate, 150 mM NaCl, 10 mM DTT, pH 7.1 at a flow rate of 0.5
mL/min. Additionally experiments were repeated with the more acidic proteins,
domains 4 and 6, where the elution buffer was changed to 20 mM Tris/Cl, 150 mM
NaCl, 10 mM DTT, pH 8.0 to examine pH effects on the gel filtration molecular mass
determinants.
Copper Binding and Interdomain Copper Exchange
All handling of proteins during the metal binding and copper exchange studies
was carried out in an N2 atmosphere chamber maintained at 18°C (Nexus Standard
Glove Box System, Vacuum Atmospheres Co.). Buffers were treated with Chelex100 resin to minimize the background level of copper present during the studies. The
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metal binding and copper exchange events were performed in a single buffer: 20 mM
MES/Na, 150 mM NaCl, pH 6.0. Copper binding was accomplished in a 10 ml
Amicon Ultra filtration cell fitted with an YM3 Millipore membrane, molecular
weight limit of 3,000 Da. For preparation of Cu-MBDl and Cu-MBD4 1.0 molar
equivalent of cu<1)(CH3 CN)4]PF6 was added to each MBD to give a final protein
concentration of 30 µM in 7 mL. The Cu(I)-protein solution was stirred for 10
minutes before exchanging the buffer four consecutive times to remove any unbound
copper. Each flow-through fraction collected during the buffer exchange was saved
for later copper analysis.
The [Cu<0(CH3 CN)4]PF6 stock solution was prepared by dissolving the metal
compound in a 2% acetonitrile matrix. The Cu(I) concentration of the stock solution
was determined via a Thermo Elemental VG PQ Excell ICP-MS (Northwestern
University). A trace metal grade Cu standard was used for calibration of the Cu(I)
stock solution concentration. Two copper calibrations were performed; the first
calibration range included 0 ppb - 100 ppb Cu and the second calibration range
included 0 ppb - 10 ppb Cu. The second calibration was used for determination of
the background copper. The mean of three ICP-MS instrumental readings was used
for all calculations of copper quantities.
Copper exchange between MBD 1 and MBD4 was executed through the
mixing of (a) Cu-MBD l with apo MBD4 for the forward reaction or (b) Cu-MBD4
with apo MBD 1 for the reverse reaction, in an inert environment with 5 minutes of
incubation at l 8°C. Afterward the solution was immediately loaded onto a 1 mL
HiTrap Q-Sepharose HP column (Amersham Pharmacia Biosciences) for separation
of the two MBDs using a linear salt gradient increasing from 150 mM NaCl to 400
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mM NaCl. Collected column fractions were analyzed in terms ofprotein
concentration and metal content using the Bio-Rad assay and ICP-MS, respectively.
The copper exchange experiments were each done with three separate molar
ratios ofCu-MBD to apo MBD (1:1, 2:1, and 1:2). Copper exchange reactions were
done in a 1.2 mL volume using 1.5 mL Eppendorftubes with protein concentrations
ranging from 10 µM to 20 µM.
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CHAPTER III
RESULTS
Cloning ofWDP MBDs
The genes for MBD1 and MBD4 were each amplified through 30 cycles of
PCR using Deep Vent DNA Polymerase (New England Biolabs). PCR products of
the MBDs double digested with the endonucleases Neal and BamHI and purified
before directionally cloning the genes the E. coli expression vector pET-2 l d.
Sequence analysis was performed on the recombinant plasmids containing MBD1
and MBD4 before commencing to synthesize protein. The sequence for each cloned
MBD is provided in Figure 6; the sequences in Figure 6 are aligned to by the
conserved metal-binding motifGMCXXC. The MBDl G85V mutant was generated
, using Stratagene's Quikchange XL site-directed mutagenesis kit. MBDl wild type
and mutant forms are both 72 amino acid residues in length with the mutation
occurring as the second most N-terminal glycine residue. MBD4 is 75 amino acids in
length and shares 47% sequence identity with MBD1.
Protein Expression in E. coli
Initially each MBD was individually cloned into the pET- 21d expression
vector and transformed into BL21 (DE3) E. coli hosts. For protein expression,
plasmid-containing cells were inoculated into LB with the appropriate antibiotic
(ampicillin in the case ofplasmid pET-21d) and incubated at 37°C until the desired
OD600 was reached, at which point protein expression was induced with 1 mM IPTG.
Figure 7 shows a 15% SDS-PAGE ofa time-course study ofMBDl protein
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MBDl

5'-MVATSTVRILGMTCQSCVKSIEDRISNLKQIISMKVSLEQGSATVKYVPSVVCLQQVCHQIGDMGFEASIAE-3'

MBD4 5'-MGTCSTTLIAIAGMTCASCVHSIEGMISQLEQVQQISVSLAEGTATVLYNPAVISPEELRAAIEDMGFEASWSE-3'

Figure 6. MBD 1 and MBD4 Amino Acid Sequences
Each MBD sequence shares the conserved GMTCXXC motif, outlined in bold, and is
approximately 70 amino acid residues in length. The mutant ofMBDl contains a
missence mutation where a conserved glycine, underlined above, is changed to
valine.
expression; the protein samples have been normalized against a background sample
(time = 0 min.) for determination of target protein overexpression. After examining
the results of the expression studies ofMBD 1 wild type, the protein was considered
to be poorly overexpressing under the given experimental conditions. Several
parameters of the protein expression protocol were changed to optimize the protein
yield.
One possible cause for the poor overexpression ofMBDl is the presence of
rare amino acid codons in the protein sequence (Novagen, 2003). Some eukaryotic
proteins contain codons seldom used in E. coli. When overexpression is induced the
low t-RNA levels of these rare codons can adversely affect the protein expression
levels. MBDl was found to contain one such rare codon, AUA, for its most N
terminal alanine residue. Rosetta E. coli cells (Novagen) contain t-RNAs for six
codons that are rarely used in E. coli, including the AUA codon present in MBDl.
For prevention of low protein yields due to rare codon usage each MBD studied was
transformed into Rosetta cells for future studies.
The MBDs were each studied for protein expression levels when using
different growth media: LB, TB, and M9 minimal. While growth media did influence
rates at which inoculated cultures reached the desired OD6oo for induction, protein
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Figure 7. Initial MBDl Time-course Expression Studies Exhibit Low Protein Yields
Experimental conditions: BL21 (DE3) as the E. coli expression host, ampicillin
resistant pET-21d expression vector, Luria broth for culture media, 37°C incubation
temperature, and 1 mM IPTG for induction.
expression levels were not discernible between the different media. In order to
determine whether basal expression levels of the target protein were masking the
protein expression induction, media was supplemented with 1-2% glucose. pET-21d
and pET-24d vectors each contain a T7 promoter sequence upstream of the target
gene for selective transcription of plasmid DNA by T7 RNA polymerase. T7 RNA
polymerase gene expression and transcription activity are regulated by the /acUV5
promoter located within the E. coli cellular DNA. The /acUV5 promoter is activated
with the addition of the lactose analog IPTG to induce protein expression. However,
the /acUV5 promoter may also be stimulated by cAMP causing an increase in basal
expression levels of target protein. The addition of glucose to media helps prevent
cAMP-triggered target protein expression (Baneyx, 1999). Protein expression studies
conducted in glucose supplemented media showed no changes from non
supplemented media.
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The antibiotic selectivity of the plasmid prevents overgrowth of the bacterial
culture by cells which lack the vector plasmid (Novagen, 2003). As a bacterial
culture proceeds from the logarithmic growth phase toward the saturation growth
phase, fewer plasmid-containing cells endure. Initially the MBDs were cloned into
pET-21d, an ampicillin resistant expression vector and yielded poor expression of
target protein. MBD1 and MBD1 mutant were both expressed using the ampicillin
analog carbenicillin which is less susceptible to the acidic pH changes that occur in
the growth medium due to bacterial metabolic processes. Replacing ampicillin with
carbenicillin did not increase protein yields.
In addition to carbenicillin and ampicillin, kanamycin was also used for
antibiotic selection. Kanamycin is less susceptible to degradation than ampicillin. In
addition, the pET- 24d vector produces less antibiotic gene product during induction
than pET-21d. This is due to the location and orientation of the P-lactamase gene
(responsible for ampicillin resistance) within pET-21d and the kan gene in pET-24d.
In both plasmids the antibiotic gene is located downstream of the T7 promoter where
mRNA synthesis is initiated. As a result, when the T7 promoter of pET-21d is
induced, target protein mRNA is produced as well as some mRNA for the ampicillin
resistant enzyme P-lactamase, resulting in an increase in antibiotic degradation after
IPTG induction. This problem is corrected in the pET-24d vector by changing the
orientation of the kan gene. Each MBD gene was shuttled from pET-21d to pET-24d
to use kanamycin for antibiotic selection of the plasmid-containing cells. Protein
expression studies conducted using pET-24d as the expression vector displayed an
improvement over previous studies performed with pET-21d. A detectable band
appeared on polyacrylamide gels of time-course protein expression studies which
corresponded well to the expected target protein molecular mass (results not shown.)
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Slowing the rate of protein synthesis can produce greater quantities of protein
in an active and soluble form. Incubation temperature and IPTG concentration during
protein expression were each examined with consideration of their effects on protein
synthesis rates. Time-course protein expression studies show little difference
between cultures incubated at 30° C and 37 °C if the incubation was continued for at
least 3 hours. Differences in OD6oo readings of the induced cultures for each
temperature during incubation periods of less than 3 hours can be contributed to the
differences in growth rates for the two temperatures. IPTG concentrations from 0.12.0 mM were studied for MBD1 protein expression. At concentrations of 1 mM
IPTG or greater MBDl was poorly overexpressed in the E. coli cells. When the
IPTG concentration was lowered to 0.7 mM or less MBDl expression was readily
detectable through SDS-PAGE analysis. The optimal concentration of IPTG for
MBDl expression was determined to be 0.5 mM. Figure 8 shows a 15% SDS-PAGE
of a time-course study of MBD1 optimized protein expression with normalized
loading volumes.
The G85V mutant of MBD1 and MBD4 expression levels were also
optimized using the same parameters as described for MBD1. Successful expression
of the MBDl mutant was not achieved during this study. MBD4 was found to
express well under the same conditions as MBD1: E. coli Rosetta cell expression
host, kanamycin resistant pET-24d expression vector, Luria broth for culture media,
37 °C incubation temperature, and 0.5 mM IPTG for induction. The expression of
MBD4 was not readily detected by staining the polyacrylamide gels of MBD4
induction studies with Coomassie Brilliant Blue. However, overexpression of MBD4
was detected without difficulty using a silver staining kit (Amersham Biosciences).
Both MBDl and MBD4 were found to be expressed with >90% of the total protein
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Figure 8. Optimized Yield for MBD l Time-course Expression Studies
Experimental conditions: Rosetta cells as the E. coli expression host, kanamycin
resistant pET-24d expression vector, Luria broth for culture media, 37°C incubation
temperature, and 0.5 mM IPTG for induction.

yield present in a soluble form as determined by comparisons of polyacrylamide gels
of the total cell extracts, the soluble protein isolated by freeze thaw extraction
treatment, and the proteins remaining in the cellular pellet after freeze thaw treatment
(results not shown).
Protein Purification
A large-scale overexpression was conducted for MBD 1 and MBD4 using a 10
liter LB culture for induction. Each 10 L induction was performed using a New
Brunswick Microferm Fermentor. Incubation conditions were set as 37°C with 500
rpm stirring, and 10 psi of aeration. The cultures were allowed to induce for 2 hours
prior to being harvested. Bacterial cellular pellets were treated to a freeze thaw
extraction to selectively release soluble proteins with a molecular mass of< 30 kDa
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Figure 9. 10 L Overexpression of MBDl and MBD4
15% Tris SDS-PAGE (A) MBDl 10 L induction. Loaded samples include (1) un
induced culture, (2) 1 hr induction aliquot, (3) 2 hr induction aliquot, and ( 4) freeze
thaw extraction. (B ) MBD4 10 L induction. Loaded samples include ( 1) un-induced
culture, (2) 2 hr induction aliquot, (3) freeze thaw extraction precipitated with TCA,
and ( 4) freeze thaw extraction.
(Johnson, 199 4). The results of the large-scale overexpression and subsequent
freeze thaw extraction treatment of MBD1 and MBD4 are shown in Figure 9 . The
MBDl and MBD4 crude protein extracts were purified using separate weak ion
exchange protocols.
Due to the acidic nature of most E. coli cellular proteins, having a pl typically
less than 6, a batch DEAE-Sepharose anion exchange was performed on crude MBD1
extract to remove most cellular proteins. The batch anion exchange was buffered to
pH 5.5. MBDl has a theoretical pl value of 7.8 (Huffman, 2001) and therefore
should not bind to the DEAE resin under acidic pH conditions. After batch anion
exchange the protein was further purified by CM-Sepharose cation exchange using an
AKTA FPLC system. The batch exchange technique was a preferred method over
directly proceeding with ion exchange chromatography by FPLC in the purification
of MBD1. The E. coli cellular proteins removed during this step bind strongly to the
DEAE resin and require extensive cleaning of the resin prior to further use.
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MBD4 has a theoretical pl value of 3.8 (Huffman, 2001) and therefore the use
of a batch ion exchange technique for cleaning the crude protein extract, as was done
with MBD1, would not be effective. Instead, crude MBD4 protein extract was
directly purified by DEAE-Sepharose anion exchange under the same conditions as
MBD1 ion exchange FPLC purification. Both proteins were purified using the same
buffer, 20 mM MES/Na, 0.1 mM EDTA, 5 mM DT T, pH 5.5, with a 0-0.5 M NaCl
salt gradient. FPLC fractions of 3.3 mL were collected during the salt gradient and
analyzed for protein content. MBDl was found to elute during fractions 45-63 with
NaCl concentrations of 0.2-0.3 M with few impurities. MBD4 eluted during fractions
60-70 at 0.4-0.45 M NaCl along some cellular proteins. Figure 10 is an SDS-PAGE
of the fractions collected during ion exchanges which contain the MBDs.
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Figure 10. Ion Exchange Chromatography of MBDl and MBD4
(A) Fractions 45, 48, 51, 5 4, 57, 60, and 63 of the CM-Sepharose cation exchange
were determined to contain MBDl. (B) Fractions 60, 62, 6 4, 66, 68, and 70 of the
DEAE-Sepharose anion exchange contained MBD4.
Protein-containing fractions from ion exchange chromatography were
combined and concentrated using an Amicon Ultra-filtration cell until the volume
was less than 2.5 mL. For the final purification step each protein solution was loaded
onto a gel filtration column containing Superdex 75 prep grade resin and eluted with
buffer (20 mM MES/Na, 10 mM DTT, 150 mM NaCl, pH 6.0). Fraction volumes of
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Figure 11. PurifiedMBOs 1 and 4
Superdex 75 gel filtration fractions containingMBOl andMBO4 run on 15% Tris
SOS-PAGE. The proteins are each considered to have been purified to homogeneity
after gel filtration.
5.1 mL were collected and analyzed by Bio-Rad and SOS-PAGE. Protein-containing
fractions collected during gel filtration for each domain are shown in Figure 11.
MBO1 andMBO4 very similar in size and thus were both collected during fractions
39 to 45 for each respective isocratic elution.
Characterization ofMBOs
The purified WOP MBOs were analyzed in terms of amino acid composition
and molecular mass in order to verify proper protein identity and lack of
contamination. Amino acid hydrolysis ofMBOl, MBO4, andMBO6 were
performed by the Texas A & M University Protein Chemistry Laboratory. The
percent amino acid composition ascertained for eachMBO agreed well with the
known values. Amino acid hydrolysis was also used for calculation of protein
concentration for each homogeneous protein sample and determination of protein
yield from a 10 L induction. Approximately 4 .5 mg ofMBOl, 27.5 mg ofMBO4, 20
mg ofMBO6 were obtained per 10 L culture. The hydrolysis results were further
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utilized for an external calibration of protein concentrations determined using the
Bradford assay with an IgG standard. The Bradford assay underestimated the
concentration of each protein studied; MBDl was underestimated by 33%, MBD4 by
92%, and MBD6 by 65%. The Bradford assay underestimated with increasing
amounts as the proteins became more acidic.
MALDI-TOF mass spectrometry data for MBDl and MBD4, shown in Figure
12, were obtained through the Michigan State Mass Spectrometry Lab. The
calculated average molecular masses of MBD1 and MBD4 are 7777 Da and 7720 Da,
respectively. For MBDl the largest peak is present at 7777.17 Da within the mass
spectrum and no other substantial peaks are detected. The MBD4 mass spectrum
shows two significant peaks at 7593.10 Da and 7724.74 Da. The larger mass,
7724.74 Da, is very close to the calculated mass of 7720 Da. The difference between
the two peak values, 131.64 Da, is readily explained upon considering the occurrence
ofN-terminal methionine-processing.

-

7777.17

MBD1

]
-

, 7593.10

MBD4

,_

7724.74

792220

....

....

Figure 12. MALDI-TOF Data for MBDl and MBD4
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The MBDs of WDP have been predicted have to distinct surface potentials
with pl values ranging from 3.8 (MBD4) to 8.7(MBD2) as detailed in Figure 3.
MBD4 was chosen to study alongside MBD1 in part because of its significantly low
pl value; MBD4 is the most acidic of the six N-terminal metal-binding domains. In
addition to MBDl and MBD4, other purified MBDs of WDP recently produced in the
laboratory of Dr. David Huffman were also analyzed including: MBD3, MBD6, and
the linked domains MBD5-6. Experimental determination of the pl values was
performed using pH 3-9 gradient gels on a Pharmacia PhastSystem with the Broad
Range pl Calibration Kit from Amersham Pharmacia Biotech. The calibration curve
constructed from the pl standards was obtained by a linear least squares fit analysis of
the data. Results of the isoelectric focusing are shown in Figure 13. As predicted by
computer modeling (Huffman, 2001), the individual isolated domains 1, 3, 4, and 6
each have a unique isoelectric point. Notably, the determined pl values for MBD l
and MBD4 were almost 3 pH units apart.
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Figure 13. Isoelectric Focusing of WDP MBDs
Determination of the isoelectric points for the individual WDP domains: MBD l pl=
6.77 (lane 1), MBD3 pl = 6.31 (lane 6), MBD4 pl = 3.85 (lane 8), MBD6 pl = 5.02
(lane 5), and MBD5-6 pl = 4.96 (lane 3). Isoelectric point protein standards (lanes 2,
4, and 7) were fit by least squares analysis for the calibration curve shown.
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Each isolated protein (MBDl, MBD4, MBD6, and MBD5-6) was analyzed by
high resolution gel filtration spectroscopy to verify sample purity and characterize the
apparent molecular masses for the domains. Two columns, Superdex 10/30 HR and
Superdex Peptide (Pharmacia Biosciences), were used for the high resolution gel
filtration studies. A single Gaussian peak was observed.for each protein sample
analyzed by high resolution gel filtration indicating an apparent lack ofprotein
aggregation. Figure 14 shows two gel filtration profiles which are representative of
the entire gel filtration experiment sample set through the differences in experimental
parameters. For each experiment UV absorbance was measured at 254 nm by FPLC.
The gel filtration profile shown ofMBD1 was conducted with MES buffer at pH 6.0
using the Superdex 10/30 HR column. The gel filtration profile ofMBD4 was
generated using phosphate buffer at pH 7 .1 and the Superdex Peptide 10/30 HR
column. Table 1 lists the molecular masses for the protein standards and MBDs with
corresponding elution volumes for each column. Both columns produced an
overestimate ofmolecular mass for the MBDs; the Peptide column showed some
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Figure 14. High Resolution Gel Filtration Profiles
For molecular mass estimation 137 µg ofMBDl was injected onto a Superdex 10/30
HR column (left); 390 µg ofMBD4 was injected onto a Superdex Peptide 10/30 HR
column (right).
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Column:

Superdex Peptide 10/30 HR

Superdex 10/30 HR

Protein Standards

V, (m� K,.

Mass(Da)

Protein Standards

v, (ml) K..,

Mass(Da)

Blue Dextran 2000
Bovine Serum Albumin
Ovalbumin
Chymotrypsinogen A
Ribonuclease A

8.20
10.09
10.95
13.06
13.99

0.123
0.179
0.316
0.377

> 106
67,000
43,000
2�.000
13.000

Blue Dextran 2000
Myoglobin
Rnase A
Cytochrome C
Aprotinin
Gastrin I
Vtamin B12
Glycine 6
Glycine 3
Glycine

8.12
9.82
10.08
10.17
11.69
14.05
16.14
17.78
18.79
19.84

0.110
0.127
0.133
0.231
0.384
0.519
0.626
0.691
0.759

> 106
17800
13700
12500
6500
2126
1355
360
189
75

Protein Unknowns
Wilson Domain 1
Wilson Domain 6
Wilson Domain 5-6

V, (m�
14.530
14.360
12.650

K,v
0.412
0.401
0.290

Mass(Da)
7777
7732
15995

Protein Unknowns
Wilson Domain 1
Wilson Domain 4
Wilson Domain 4'
Wilson Domain 6
Wilson Domain 6'
Wilson Domain 5-6

V, (ml)
10.91
10.41
10.46
10.85
10.94
9.45

K,.
0.181
0.148
0.152
0.177
0.183
0.086

Mass(Da)
7777
7720
7720
7732
7732
15995

Cale. Mass (Da)
12,200
13.100
25,500

Cale. Mass (Da)
9.700
12,600
12.300
10.000
9,600
20.600

Table 1. HR Gel Filtration Data for WDP MBDs
High resolution gel filtration of the MBDs was conducted with two separate columns:
Superdex 10/30 HR and Superdex Peptide 10/30 HR. All separations performed with
the Superdex 10/30 HR column used a 20 mM MES/Na, 10 mM DTT, 150 mM NaCl,
pH 6.0 buffer. The Superdex Peptide 10/30 HR column was eluted with 20 mM
phosphate, 150 mM NaCl, 10 mM DTT, pH 7.1 buffer for each protein
characterization. MBD4 and MBD6 were also eluted from the Peptide column using
20 mM Tris/Cl, 150 mM NaCl, 10 mM DTT, pH 8.0; use of the Tris buffer is denoted
by an asterisk.
improvement over the Superdex 10/30 HR column in determining mass. In addition,
adjusting the elution buffer pH for the Peptide column was shown to affect the elution
volume of the more acidic proteins, MBD4 and MBD6, and subsequent molecular
mass calculation.
Copper Transfer
Currently, no studies of copper (I) exchange between individual MBDs of
WDP have been published. Previous studies have all examined the copper binding
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characteristics of the domains using from two to six of the MBDs either by mutating
the cysteine residues of the metal binding site GMCXXC motif or by cloning
methods. Preparation of the metallated proteins was performed in an N2 atmosphere
chamber maintained at 18°C (Vacuum Atmospheres). Initial control studies of the
apo and Cu-loaded MBDs determined that successful separation of the proteins could
be accomplished using anion exchange chromatography, specifically using a 1 mL
HiTrap Q-Sepharose HP column (Amersham Pharmacia Biosciences). In Figure 15
the elution profiles for the metallated and apo forms of both proteins are shown as
detected at 254 nm absorbance. No significant differences were observed in the
anion exchange elution volumes between the apo and metallated forms of the
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Figure 15. Separation of MBDl and MBD4 using Anion Exchange Chromatography
In control studies consistent results were obtained determining that MBD1 eluted
from the column in fractions 2-3 and MBD4 eluted in fractions 14-17. Elution
volumes were not affected by the presence of copper.
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proteins, although UV absorbance values for the metallated proteins were
significantly increased over those of apo proteins with similar concentrations. For
purposes of protein solubility all metallation and copper exchange experiments were
performed using the buffer: 20 mM MES/Na, 150 mM NaCl, pH 6.0. In order to
prevent the occurrence of excess copper present after the metallation process, a 1.0
molar equivalent was incubated with the protein followed by successive buffer
exchanges for removal of any unbound metal. Both the apo and metallated stock
solutions of protein for each domain were analyzed for copper content and protein
concentration. The protein concentrations were determined by amino acid hydrolysis
and thiol quantitation (Thiol and Sulfide Quantitation Kit by Molecular Probes).
Protein concentrations were estimated within 5% difference between the two
methods; the results obtained by thiol determination were selected for further
calculations. The copper content of the protein containing fractions was analyzed
using ICP-MS. Protein concentration and copper content of the control reactions are
listed in Table 2. The ability of each protein to readily bind copper was demonstrated
through high percentage of metal bound protein present after incubation with the
metal for 10 minutes. During the metallation process 97% of MBDl and 84% of
MBD4 acquired copper. Four volumes of buffer were exchanged immediately after
metallation using a 10 mL Amicon ultra filtration cell theoretically leaving less than
0.01 µM of free Cu(I) in solution.
Concentrntion µM
Control

Cu-MBD1
Apo MBD1
Cu-MBD4
Apo MBD4

(MBD1)

(Cu-MBD1)

(MBD4)

8.68
7.97

8.41
5.08

D
D

D
D

D
D

11.92
8.43

(Cu-MBD4)

D

1000

0.77

Table 2. Copper Content and Protein Concentration of Control Tests
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The observed increase in absorbance at 254 run of metal-bound proteins over
apo proteins allowed for the copper transfer experiments to be qualitatively
monitored through UV measurement during FPLC separation of the proteins. In
Figure 16 .the absorbance profiles collected during the_anion exchange
chromatography separation of the proteins are depicted for the forward (Cu-MBDl ---+
MBD4) and reverse (Cu-MBD4---+ MBDl) reactions. The profiles show a decrease
in absorbance for the copper donor as its quantity of metallated protein is reduced and
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Figure 16. FPLC Absorbance Profiles for Copper Exchange MBDl and MBD4
Separation

a corresponding increase in absorbance for the copper acceptor when compared to the
initial absorbance states shown in Figure 15.
Additionally the copper exchanges of differing molar ratios between the donor
and acceptor reinforce a pattern of copper exchange. When the quantity of copper
donor was doubled and acceptor kept the same, the abs.orbance peak for the donor
retained a high value and the acceptor peak increased only slightly indicating little
additional copper was exchanged in the presence of excess donor. Conversely when
the copper acceptor is doubled and the donor concentration unchanged the donor peak
changed more dramatically as more copper was received during the exchange.
The copper content for each protein fraction collected after copper exchange
was analyzed using ICP-MS. Samples were diluted during the analysis to reduce
interferences caused by NaCl. The molar concentrations of the initial and
equilibrium copper bound proteins have been calculated for the metal exchange
studies. Additionally, the copper exchange constant was calculated; the copper
exchange equation is given in Figure 17. Table 3 lists the copper distribution of each
copper exchange experiment and the Kexchange value. The Kexchange values for the
forward and reverse exchange reactions indicative equilibrium was reached in the
allotted time before separation of the proteins was conducted. The average Kexchange
value is 0.69 as determined by a linear regression analysis.
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Figure 17. Calculation of the Copper Exchange Constant
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Initial Concentration ilM

Eguilibrimn Concentration ilM

[MBD1]

[Cu-MBD1]

[MBD4]

[Cu-MBD4]

[Cu-MBD1]

[Cu-MBD4]

MBD1
MBD1
MBD1

8.68
8.68
8.68

8.41
8.41
8.41

8.43
8.43
8.43

0.77
0.77
0.77

4.54
2.76
3.17

3.95
3.74
3.99

0.80
0.92
0.89

MBD4
MBD4
MBD4

7.97
7.97
7.97

5.08
5.08
5.08

11.92
11.92
11.92

10.00
10.00
10.00

3.74
3.82
3.34

4.44
4.43
4.44

0.67
0.64
0.82

MBD1
MBD1
MBD1

17.36
17.36
17.36

16.82
16.82
16.82

8.43
8.43
8.43

0.77
0.77
0.77

8.57
7.20
6.88

3.74
3.03
3.03

0.82
0.79
0.85

MBD4
MBD4
MBD4

7.97
7.97
7.97

5.08
5.08
5.08

23.84
23.84
23.84

20.00
20.00
20.00

4.48
3.82
3.94

11.18
10.21
10.35

0.69
0.81
0.78

MBD1
MBD1
MBD1

8.68
8.68
8.68

8.41
8.41
8.41

16.86
16.86
16.86

1.54
1.54
1.54

2.41
2.44
2.12

3.99
3.60
3.50

0.81
0.69
0.81

MBD4
MBD4
MBD4

15.94
15.94
15.94

10.16
10.16
10.16

11.92
11.92
11.92

10.00
10.00
10.00

5.52
4.67
5.44

3.82
3.75
4.45

0.89
1.11
1.15

Cu Donor

K.xch!!:!Q!

Table 3. Copper Exchange Distribution Between MBD1 and MBD4
Protein concentration calculations are based total reaction volume (1.2 mL), stock
concentrations (listed in Table 2), and the injection volume (1 mL) for each copper
exchange separation.
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CHAPTER IV
DISCUSSION
The objective of this study was to isolate and characterize the N-terminal
MBDl and MBD4 of Wilson disease protein and further determine their ability to
reversibly exchange copper between. The disease-causing missence mutation of
MBDl , G85V, was also to be investigated in comparison to the wild type.
While the G85V was successfully cloried into E. coli expression vectors pET21 d and pET-24d, the protein could not readily be expressed and therefore
comparisons between the mutant and wild type of MBD1 could not be accomplished.
The mutant is likely to be misfolded and less stable than the wild type creating many
difficulties in successfully obtaining soluble recombinant protein. The application of
a fusion tag for expression of the mutant could increase protein yields. Fusion tags
are a common method of improving solubility and correct folding of recombinant
proteins through fusion to another protein which is highly soluble. Another approach
to improving the expression would be examining incubation temperatures more
thoroughly to include 15° C and 20° C. Lower temperatures reduce the rate of
expression and can increase the protein yield as a result.
In contrast to MBD1 mutant, both MBD1 and MBD4 yielded successful
results when expressed in E coli under optimized conditions. The proteins were each
purified to homogeneity and characterized by high resolution gel filtration, MALDI
mass spectrometry, isoelectric focusing, and amino acid hydrolysis. Copper transfer
studies were conducted on MBD1 and MBD4.
High resolution gel filtration studies of MBD1 and MBD4 yielded single
Gaussian absorbance profiles for each protein. Molecular mass determinations based
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upon high resolution gel filtration using two different columns consistently
overestimated the size of the MBDs. This result is not unexpected since molecular
mass calibration curves using gel filtration are less accurate for low mass proteins.
The purified proteins were each characterized using MALDI mass
spectrometry for verification of the expected molecular masses based upon the known
amino acid sequences. Mass spectrometry data determined both proteins were of the
expected mass within an experimental error of± 4 Da. Additionally MBD4 was also
present in the methionine-processed form.
The isoelectric points of several of the purified MBDs of WDP were
measured. Although the experimentally determined isoelectric points of the were
generally found to have lower values than predicted, with the exception of MBD4,
discrepancies in the exact sequence of the recombinant proteins can account for these
differences. The sequences of the metal-binding domains have been determined by
sequence alignment with known copper binding ATPases. Different research groups
have reported some variation in the assignment of the exact beginning and end of the
domains; generally the differences are only a few additional or omitted residues on
each end. If these variant residues are charged the isoelectric points of the domains
will be slightly different. For purposes of examining copper transfer between the
MBDs based upon surface charge these differences should not effect the metal
binding site environment since the N- and C- termini of the protein are located on the
opposite side of the molecule as shown in Figure 3.
The differences in isoelectric point values between MBD 1 and MBD4 were
the basis for testing whether the two domains could exchange copper. Additionally
the difference in isoelectric points allowed for an easy separation of the proteins by
anion exchange chromatography. Anion exchange control experiments were

conducted to examine the elution times of the apo and metallated·forms of both
proteins. MBDl consistently eluted in the early fractions possible and was concluded
not to bind to the column. No changes in elution time were noted between apo and
metallated MBD1. A single Gaussian peak was observed during the elution of
MBD l with increase absorbance due to the presence of copper. Apo MBD4 showed
two overlapping elution peaks in control tests. As the quantity of metallated MBD4
increased the first peak diminished and the second peak increased. These results
indicate the apo and metallated forms of MBD4 might be interacting with the anion
exchange resin in different manner. Elution times of MBD4 were unaffected by
whether the protein was metallated with the protein eluting in fractions 14-17
consistently. MBD4 also showed an absorbance increase with copper present.
The buffers used for the copper exchange experiments and subsequent anion
exchange separation were each treated with Chelex-100 resin to minimize
background levels of copper. Inevitably the MBDs acquired some copper during
purification and the metal exchange studies. The ability of the proteins to strip
copper from the buffers is indicative of their high affinity for the metal. MBD1
exhibited an increased instability over MBD4, MBD6, and MBDS-6. Determining
the optimum storage conditions (i.e. buffer, pH, salt concentration) for MBDl would
likely correct this problem.
The distinct properties of the two MBDs predicted the possibility for copper
exchange to occur and indeed when examined in vitro this was found to be the case.
The electrostatic surface differences between the MBDs are thought to enable the
proper positioning of the proteins in order for the copper exchange event to occur.
Experimental results indicate equilibrium is reached quickly, within less than 5
minutes. An attempt was made to replicate physiological conditions by keeping
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copper concentrations low within the estimated physiological concentrations
(Tsivkovskii, 2002) with upper limits of 20 µM. The transfer experiments were
conducted as near to physiological pH as the stability of the MBDs allowed.
However, MBDl exhibited increased instability and insolubility as pH neared 7. This
is most likely due to the isoelectric point (6.7) of MBDl being near this pH. As a
result, the metal transfer studies were performed at pH 6. Temperature considerations
for the experimental design were limited to the environment of the anaerobic glove
box utilized during the study. Although 37°C would have been preferred to simulate
physiological conditions, the glove box was only able to maintain a steady
temperature of l 8 °C for the transfer experiments and the resources to set up an
incubator within the glove box were inaccessible.
Although copper exchange was observed between the individual domains
MBD1 and MBD4 ofWDP in vitro whether this is the same case in vivo with the
native protein remains to be seen. Currently the structure of theN-terminal metal
binding region ofWDP is not known and therefore the relative arrangement of the six
MBDs within the protein is also unresolved. The linking loops between the MBDs of
WDP have differing lengths with the longest being between and the fourth and fifth
domains and the shortest between the fifth and sixth domains (Amesano, 2001b).
The ability of the MBDs to exchange copper would be dependent on their surface
charges as well as their faculty to properly align for exchange to occur requiring a
certain degree of mobility within theN-terminal metal-binding region ofWDP. The
changes in the conformation ofN-terminal metal-binding region ofWDP with
increasing molar ratios of copper reported indicate some movement may occur
(DiDonato, 2000). MBD4 would appear to be a good candidate for participation in
domain-domain copper exchange since it possesses the most potential mobility of the
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domains based upon the length of its linking loops. In support of MBD4 playing a
role in transferring copper to some or all of the other domains are the results of yeast
two-hybrid studies examining Atoxl interactions with the individual MBDs of WDP
(van Dongen, 2004). The strongest interactions were detected between the
metallochaperone and MBD4 and to a lesser degree with MBD 1 and MBD2.
The determination of MBD 1 and MBD4 being capable of exchanging copper
in vitro suggests that domain-domain copper transfer within WDP is plausible under

the proper conditions and further investigations will be required to determine if these
conditions do indeed exist in vivo. Determination of the existence of domain-domain
copper exchange events within the native state of WDP will require some careful
planning. The next step will require synthesis of all six MBDs individually and
additionally as one unit with the domains linked together. Protein-protein interaction
detection methods such as two-hybrid analysis, cross-linking, fluorescence energy
transfer (FRET) or surface plasmon resonance (SPR) could be employed to detect the
exchange. However, the small size of the domains and relative proximity to each
other will complicate the results of these methods which are more commonly utilized
to detect interactions between molecules that are not attached. It is likely more than
one approach of analyzing protein-protein interactions will be required to interpret
the results properly. In combination analyzing domain-domain interactions the
structure of the N-terminus metal-binding region could be determined using NMR
techniques for analysis of which MBDs are likely to interact based on spatial
orientation.
Assuming domain-domain copper exchange occurs within WDP prompts the
question of whether preferential acceptor -donor pairs exist. Similarly to studies
performed with Atoxl (Larin, 1999; van Dongen, 2004; Walker, 2004), a single
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copper loaded MBD could incubated with apo MBD 1-6 and examined in terms of if
copper exchange occurred and which MBD accepted the copper. Although this
approach may not be conclusive in itself, as a single MBD will have greater
accessibility than in the native state, some insight may be provided as to which
MBDs are more likely to interact.
The implications of copper exchange taking place between MBDs within
WDP may point to a new mechanism of regulation for the protein. Several studies
have suggested that the first four MBDs may serve a separate function than the latter
two MBDs. Is so, a model of protein regulation using the ability of the domains to
transfer copper between each other for purposes of monitoring activities such as
copper transport activity of the intramembrane metal-binding site CPC, catalytic
phosphorylation activity, and interaction with the metallochaperone Atoxl could
explain the functional non-equivalence of the individual MBDs of WDP. Under this
model copper would be delivered via Atoxl to one of the first four domains (Larin,
1999). The subsequent transfer of copper to one of the latter two domains would be
dependent of upon the quantity of copper present effecting the regulation of copper
transport activity (Forbes, 1999), catalytic phosphorylation activity (Huster, 2003),
and intracellular protein trafficking (Cater, 2004). For MBD5 and MBD6 have been
indicated to be crucial for these events to occur while MBDs one through four have
either been identified as not necessary or undetermined as to their roles in these
copper dependent activities. If the MBDs of WDP are capable of exchanging copper
many of the protein's copper mediated activities could be affected.
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